CYP3A4*1G polymorphism and the ABCB1-C3435T polymorphism has been shown to affect tacrolimus exposure and the extent of its interaction with diltiazem in Chinese pediatric RNS patients (Wang et al., 2021). The gene discussed is ABCB1; the disease is renal nutcracker syndrome.